Reportlinker Adds Neurology Devices Market Outlook in United States to 2017 - Neurostimulation Devices, Interventional Neurology and Others

NEW YORK, April 14, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Neurology Devices Market Outlook in United States to 2017 – Neurostimulation Devices, Interventional Neurology and Others

http://www.reportlinker.com/p0479911/Neurology-Devices-Market-Outlook-in-United-States-to-2017-–-Neurostimulation-Devices-Interventional-Neurology-and-Others.html

Neurology Devices Market Outlook in United States to 2017 – Neurostimulation Devices, Interventional Neurology and Others

Summary

GlobalData's new report, "Neurology Devices Market Outlook in United States to 2017 – Neurostimulation Devices, Interventional Neurology and Others" provides key market data on the United States Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories – CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Market size and company share data for Neurology Devices market categories – CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within six market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.

- 2010 company shares and distribution shares data for each of the six market categories.

- Global corporate-level profiles of key companies operating within the United States Neurology Devicesmarket.

- Key players covered include Medtronic, Inc., Boston Scientific Corporation, St. Jude Medical, Inc., Cyberonics, Inc., DePuy, Inc., Integra LifeSciences Holdings Corporation and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the United States Neurology Devices competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution – Identify, understand and capitalize.

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 9

1.2 List of Figures 13

2 Introduction 15

2.1 What is This Report About? 15

3 Neurology Devices In United States 16

3.1 Neurology Devices, Market Segmentation 16

3.2 Neurology Devices, United States, Overall Revenue ($m), 2003-2017 17

3.3 Neurology Devices Market, United States, Revenue Mix ($m), 2010 19

3.4 Neurology Devices Market, United States, Category Contribution (%), 2010 20

3.5 Neurology Devices, United States, Category Volume (Units), 2003-2017 26

3.6 Neurology Devices, United States, Company Share (2009-2010) 31

4 CSF Management In United States 33

4.1 CSF Management, Market Segmentation 33

4.2 CSF Management Market, United States, Revenue Mix ($m), 2010 34

4.3 CSF Management Market, United States, Segment Contribution (%), 2010 35

4.4 CSF Management Overall Revenue (2003-2017) 36

4.5 CSF Management Overall Volume (2003-2017) 40

4.6 CSF Management Average Price (2003-2017) 43

4.7 CSF Management Distribution Share (2009-2010) 44

4.8 CSF Management, United States, Company Share (2009-2010) 45

5 Interventional Neurology In United States 46

5.1 Interventional Neurology, Market.Segmentation 46

5.2 Interventional Neurology Market, United States, Revenue Mix ($m), 2010 47

5.3 Interventional Neurology Market, United States, Segment Contribution (%), 2010 48

5.4 Interventional Neurology Overall Revenue (2003-2017) 49

5.4.1 Embolic Systems Revenue 2003-2010 53

5.4.2 Navigational Systems Revenue 2003-2010 57

5.5 Interventional Neurology Overall Volume (2003-2017) 61

5.5.1 Embolic Systems Volume 2003-2010 65

5.5.2 Navigational Systems Volume (Units) 2003-2010 67

5.6 Interventional Neurology Average Price (2003-2017) 71

5.7 Interventional Neurology Distribution Share (2009-2010) 72

5.8 Interventional Neurology, United States, Company Share (2009-2010) 73

6 Neurological Diagnostic Equipment In United States 75

6.1 Neurological Diagnostic Equipment, Market.Segmentation 75

6.2 Neurological Diagnostic Equipment Market, United States, Revenue Mix ($m), 2010 76

6.3 Neurological Diagnostic Equipment Market, United States, Segment Contribution (%), 2010 77

6.4 Neurological Diagnostic Equipment Overall Revenue (2003-2017) 78

6.5 Neurological Diagnostic Equipment Overall Volume (2003-2017) 82

6.6 Neurological Diagnostic Equipment Average Price (2003-2017) 86

6.7 Neurological Diagnostic Equipment Distribution Share (2009-2010) 87

6.8 Neurological Diagnostic Equipment, United States, Company Share (2009-2010) 88

7 Neurostimulation Devices In United States 90

7.1 Neurostimulation Devices, Market Segmentation 90

7.2 Neurostimulation Devices Market, United States, Revenue Mix ($m), 2010 91

7.3 Neurostimulation Devices Market, United States, Segment Contribution (%), 2010 92

7.4 Neurostimulation Devices Overall Revenue (2003-2017) 93

7.5 Neurostimulation Devices Overall Volume (2003-2017) 97

7.6 Neurostimulation Devices Average Price (2003-2017) 101

7.7 Neurostimulation Devices Distribution Share (2009-2010) 102

7.8 Neurostimulation Devices, United States, Company Share (2009-2010) 103

8 Neurosurgical Products In United States 105

8.1 Neurosurgical Products, Market Segmentation 105

8.2 Neurosurgical Products Market, United States, Revenue Mix ($m), 2010 106

8.3 Neurosurgical Products Market, United States, Segment Contribution (%), 2010 107

8.4 Neurosurgical Products Overall Revenue (2003-2017) 108

8.5 Neurosurgical Products Overall Volume (2003-2017) 112

8.6 Neurosurgical Products Average Price (2003-2017) 115

8.7 Neurosurgical Products Distribution Share (2009-2010) 116

8.8 Neurosurgical Products, United States, Company Share (2009-2010) 117

9 Radiosurgery In United States 119

9.1 Radiosurgery, Market Segmentation 119

9.2 Radiosurgery Market, United States, Revenue Mix ($m), 2010 120

9.3 Radiosurgery Market, United States, Segment Contribution (%), 2010 121

9.4 Radiosurgery Overall Revenue (2003-2017) 122

9.5 Radiosurgery Overall Volume (2003-2017) 126

9.6 Radiosurgery Average Price (2003-2017) 129

9.7 Radiosurgery Distribution Share (2009-2010) 130

9.8 Radiosurgery, United States, Company Share (2009-2010) 131

10 Overview of Key Companies in United States Neurology Devices Market 132

10.1 Medtronic, Inc. 132

10.1.1 Company Overview 132

10.1.2 Share in the United States Neurology Devices Market 132

10.2 Boston Scientific Corporation 133

10.2.1 Company Overview 133

10.2.2 Share in the United States Neurology Devices Market 133

10.3 St. Jude Medical, Inc. 134

10.3.1 Company Overview 134

10.3.2 Share in the United States Neurology Devices Market 134

10.4 Cyberonics, Inc. 135

10.4.1 Company Overview 135

10.4.2 Share in the United States Neurology Devices Market 135

10.5 DePuy, Inc. 136

10.5.1 Company Overview 136

10.5.2 Share in the United States Neurology Devices Market 136

10.6 Integra LifeSciences Holdings Corporation 137

10.6.1 Company Overview 137

10.6.2 Share in the United States Neurology Devices Market 137

10.7 Terumo Corporation 138

10.7.1 Company Overview 138

10.8 Nihon Kohden Corporation 138

10.8.1 Company Overview 138

10.9 Elekta AB 139

10.9.1 Company Overview 139

10.10 Micrus Endovascular Corporation 139

10.10.1 Company Overview 139

10.11 Cadwell Laboratories, Inc. 139

10.11.1 Company Overview 139

10.12 ev3 Inc. 140

10.12.1 Company Overview 140

10.13 B. Braun Melsungen AG 140

10.13.1 Company Overview 140

10.14 Mizuho Ikakogyo Co., Ltd. 140

10.14.1 Company Overview 140

10.15 Accuray Incorporated 141

10.15.1 Company Overview 141

10.16 CareFusion Corporation 141

10.16.1 Company Overview 141

10.17 Natus Medical Incorporated 141

10.17.1 Company Overview 141

10.18 Covidien plc 142

10.18.1 Company Overview 142

10.19 Sophysa S.A. 142

10.19.1 Company Overview 142

10.20 KARL STORZ GmbH & Co. KG 142

10.20.1 Company Overview 142

11 Neurology Devices Market Pipeline Products 143

12 Financial Deals Landscape 150

12.1 Acquisition 150

12.1.1 Impulse Monitoring Acquires Great Lakes Intraoperative Neuromonitoring 150

12.1.2 Boston Scientific Acquires Remaining Stake In Intelect Medical 151

12.1.3 Vycor Medical Completes Acquisition Of NovaVision 153

12.1.4 Synthes Acquires The Anspach Effort 154

12.1.5 Stryker Acquires Porex Surgical 155

12.1.6 Cardinal Health Sells 13.7% Stake In Carefusion 156

12.1.7 HealthMed Services Acquires Neural Communicator 157

12.1.8 Masimo Completes Acquisition Of SEDLine 158

12.1.9 Johnson & Johnson Completes Acquisition Of Micrus Endovascular 159

12.1.10 K-Kitz Acquires Bacterin In Reverse Acquisition 161

12.1.11 Medtronic Acquires Axon Systems 162

12.1.12 Covidien Completes Acquisition Of ev3 For $2.6 Billion 163

12.2 Partnerships 165

12.2.1 Boston Scientific Enters Into Partnership With Greatbatch Medical 165

12.2.2 Synergetics USA Enters Into Co-Development Agreement With Retinal Solutions 166

12.2.3 EndoStim Enters Into an Agreement With Arizona State University 167

13 Recent Developments 168

13.1 Strategy and Business Planning 168

13.1.1 Jan 04, 2011: NeuroMetrix To Shift Business Focus To Diabetes 168

13.1.2 Dec 17, 2010: Accuray Establishes Medical Affairs Function 169

13.1.3 Nov 09, 2010: Medtronic Opens New Distribution Center In Elizabeth, New Jersey 169

13.1.4 Nov 02, 2010: InVivo Therapeutics Opens New Manufacturing And Development Facility In Medford, Massachusetts 169

13.1.5 Oct 21, 2010: Collagen Matrix Expands Operations And Moves Corporate Headquarters To Oakland, New Jersey 170

13.1.6 Aug 26, 2010: Pico-Tesla Opens New Facility In Michigan 170

13.1.7 Aug 24, 2010: Cyberonics Signs Epilepsy Technology Agreements With NeuroVista In Field Of EEG-based Seizure Detection 171

13.1.8 Aug 20, 2010: Integra Opens Center For Research, Education And Training In Irvine, California 171

13.1.9 Aug 19, 2010: Boston Scientific To Invest In New Products: CEO 172

13.1.10 Aug 10, 2010: CareFusion Announces Company-Wide Restructuring 172

13.1.11 Jun 02, 2010: B. Braun Announces Construction Of New Infusion Technology Facility In Melsungen, Germany 172

13.1.12 May 06, 2010: Swedish Cancer Institute And Elekta Renew Partnership Agreement 173

13.1.13 Apr 20, 2010: Siemens Opens National Customer Service Headquarters For 24x7 Service And Support 173

13.2 Legal and Regulatory 174

13.2.1 Jan 20, 2011: St. Jude Medical Reaches Settlement With DOJ 174

13.2.2 Jan 11, 2011: Boston Scientific Reaches Settlement With Medinol 174

13.2.3 Dec 09, 2010: Medtronic Receives Subpoena From US Government For Certain Neurostimulation Devices 174

13.2.4 Nov 10, 2010: St. Jude Medical And AGA Medical Announce Early Termination Of HSR Waiting Period 175

13.2.5 Nov 02, 2010: CSI Settles Employee Lawsuit With ev3 175

13.2.6 Sep 23, 2010: St. Jude Medical Faces Derivative Suit From Shareholders 175

13.2.7 Aug 10, 2010: Best Medical Files Patent Infringement Lawsuit Against Accuray 175

13.2.8 Jul 12, 2010: Law Offices Of Howard G. Smith Investigates Micrus Acquisition For Shareholders 176

13.2.9 Jul 06, 2010: ev3 Agrees To Settle Stockholder Litigation 176

13.2.10 Jun 01, 2010: Finkelstein Thompson LLP Announces Investigation Of ev3 176

13.2.11 Apr 09, 2010: Robbins Geller Files Class Action Suit Against Boston Scientific 176

13.3 Government and Public Interest 177

13.3.1 Feb 16, 2011: University Of Minnesota Researchers Receive $3m Grants To Create Robotic Devices And Computer Vision Algorithms For Early Detection Of Childhood Mental Disorders 177

13.3.2 Feb 15, 2011: Mayo Clinic Researchers Develop WINCS Device To Measure Brain Chemistry During Deep Brain Stimulation 178

13.3.3 Jan 24, 2011: Deep Brain Stimulation May Help Hard-To-Control High Blood Pressure: Case Study 179

13.3.4 Jan 18, 2011: Stents Help Stroke Victims When Other Treatments Fails: Research At ISET 179

13.3.5 Dec 21, 2010: Boston Scientific Receives Notices Of Deficiency From IRS 180

13.3.6 Dec 16, 2010: Researchers Suggest Diagnostic Criteria For Posttraumatic Stress Disorder Are Lacking 180

13.3.7 Nov 29, 2010: Neuro Kinetics Earns Approval From Health Canada To Sell Diagnostic Devices In Canada 181

13.3.8 Nov 14, 2010: Mental Introspection Increases As Brain Areas Begin To Act In Sync: Georgetown University Medical Center 182

13.3.9 Oct 25, 2010: Radiation Therapy Improves Painful Condition Associated With MS: ASTRO 182

13.3.10 Oct 08, 2010: Senator Grassley Questions VA Official's Relationship With Medtronic 183

13.3.11 Oct 06, 2010: Salk Researchers Map Functional Connections Between Retinal Neurons At Single-Cell Resolution 183

13.3.12 Sep 24, 2010: Scarless Brain Surgery Is New Option For Patients: UCSD And University Of Washington Study 185

13.3.13 Sep 14, 2010: FDA Advisory Committee To Discuss Clinical Trial Design Issues For Neurological Devices 186

13.3.14 Sep 08, 2010: SMU-Led Research Center Aims To Connect Brain Signals To Robotic Limbs 186

13.3.15 Aug 25, 2010: Research Heralds Potential For Early Diagnosis Of Degenerative Brain Disorders 188

13.3.16 Aug 22, 2010: Gene Scan Finds Link Across Array Of Childhood Brain Disorders 188

13.3.17 Aug 11, 2010: Boston Scientific Resolves Corporate Warning Letter 190

13.3.18 Jul 22, 2010: Stanford University School Of Medicine Seeks Patient Enrollment For Alzheimer's Study 190

13.3.19 Jul 12, 2010: MRI Better Than CT Scans At Diagnosing Stroke: New Guideline 190

13.3.20 Jun 30, 2010: New Study Identifies Best Tests For Predicting Alzheimer's Disease: Study 191

13.3.21 Jun 22, 2010: UCLA Brain Scanning Study Has Implications For Advertising, Public Health Campaigns 192

13.3.22 Jun 03, 2010: Governor Designates Cleveland Health And Technology Corridor An Ohio Hub Of Innovation And Opportunity 193

13.3.23 May 11, 2010: Stereotactic Radiosurgery Is Safe And Effective For Selected Children With Arteriovenous Malformations: Mayo Clinic 194

13.3.24 May 04, 2010: Stereotactic Radiosurgery Successful For Most Patients With Large Acoustic Neuromas: Mayo Clinic 195

13.3.25 May 03, 2010: Imaging Study Discovers Brain Development Differences In Kids With Fragile X Syndrome: Study 196

13.3.26 Apr 30, 2010: Tiny Particles May Help Surgeons By Marking Brain Tumors 197

13.3.27 Apr 19, 2010: Surgeons Use Brain Port Device To Treat Brain Cyst 198

13.3.28 Apr 18, 2010: Scientists Develop Brain-Recording Device To Control Seizures 199

13.3.29 Apr 16, 2010: Clinical Study Shows Patients Gain Limb Movement Years After Stroke 200

13.3.30 Apr 09, 2010: CDRH: Research Needed To Explore Side Effects Of Pediatric Devices 201

13.3.31 Apr 01, 2010: UC Researchers Quantify Benefits Of Minimally Invasive Removal For Tumors 201

13.4 Product News 203

13.4.1 Aug 10, 2010: NKI To Present Two Research Studies On I-Portal NOTC System At Barany Society Conference 203

13.4.2 Jul 15, 2010: Elekta To Highlight Intelligent Cancer Management Solutions At 2010 AAPM Annual Meeting 203

13.4.3 May 05, 2010: Terumo Announces Its Program For The Global Embolization Symposium And Technologies (GEST) Meeting 204

14 Appendix 205

14.1 Definitions of Markets Covered in the Report 206

14.1.1 Neurology Devices 206

14.2 Research Methodology 209

14.3 Secondary Research 209

14.4 Primary Research 210

14.5 Models 210

14.6 Forecasts 211

14.7 Expert Panels 211

14.8 GlobalData Consulting 211

14.9 Currency Conversion 211

14.10 Contact Us 212

14.11 Disclaimer 2

1.1 List of Tables

Table 1: Neurology Devices, United States, Overall Revenue ($m), 2003-2017 18

Table 2: Neurology Devices Market, United States, Category Contribution (%), 2010 20

Table 3: Neurology Devices, United States, Cross-Category Analysis, 2003-2017 21

Table 4: Neurology Devices, United States, Overall Revenue ($m), Historic, 2003-2010 23

Table 5: Neurology Devices, United States, Overall Revenue ($m), Forecast, 2010-2017 25

Table 6: Neurology Devices, United States, Category Volume (Units), 2003-2017 26

Table 7: Neurology Devices, United States, Category Volume (Units), Historic, 2003-2010 28

Table 8: Neurology Devices, United States, Category Volume (Units), Forecast, 2010-2017 30

Table 9: Neurology Devices, United States, Company Share by Revenue ($m), 2009-2010 32

Table 10: CSF Management Market, United States, Segment Contribution (%), 2010 35

Table 11: CSF Management, United States, Revenue ($m) by Segment, Historic, 2003-2010 37

Table 12: CSF Management, United States, Revenue ($m) by Segment, Forecast, 2010-2017 39

Table 13: CSF Management, United States, Volume (Units) by Segment, Historic, 2003-2010 40

Table 14: CSF Management, United States, Volume (Units) by Segment, Forecast, 2010-2017 42

Table 15: CSF Management, United States, Average Price ($), Historic, 2003-2010 43

Table 16: CSF Management, United States, Average Price ($), Forecast, 2010-2017 43

Table 17: CSF Management, United States, Distribution Share by Revenue ($m), 2009-2010 44

Table 18: CSF Management, United States, Company Share by Revenue ($m), 2009-2010 45

Table 19: Interventional Neurology Market, United States, Segment Contribution (%), 2010 48

Table 20: Interventional Neurology, United States, Revenue ($m) by Segment, Historic, 2003-2010 50

Table 21: Interventional Neurology, United States, Revenue ($m) by Segment, Forecast, 2010-2017 52

Table 22: Embolic Systems, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 54

Table 23: Embolic Systems, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 56

Table 24: Navigational Systems, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 58

Table 25: Navigational Systems, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 60

Table 26: Interventional Neurology, United States, Volume (Units) by Segment, Historic, 2003-2010 62

Table 27: Interventional Neurology, United States, Volume (Units) by Segment, Forecast, 2010-2017 64

Table 28: Embolic Systems, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 65

Table 29: Embolic Systems, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 66

Table 30: Navigational Systems, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 67

Table 31: Navigational Systems, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 69

Table 32: Interventional Neurology, United States, Average Price ($), Historic, 2003-2010 71

Table 33: Interventional Neurology, United States, Average Price ($), Forecast, 2010-2017 71

Table 34: Interventional Neurology, United States, Distribution Share by Revenue ($m), 2009-2010 72

Table 35: Interventional Neurology, United States, Company Share by Revenue ($m), 2009-2010 74

Table 36: Neurological Diagnostic Equipment Market, United States, Segment Contribution (%), 2010 77

Table 37: Neurological Diagnostic Equipment, United States, Revenue ($m) by Segment, Historic, 2003-2010 79

Table 38: Neurological Diagnostic Equipment, United States, Revenue ($m) by Segment, Forecast, 2010-2017 81

Table 39: Neurological Diagnostic Equipment, United States, Volume (Units) by Segment, Historic, 2003-2010 83

Table 40: Neurological Diagnostic Equipment, United States, Volume (Units) by Segment, Forecast, 2010-2017 85

Table 41: Neurological Diagnostic Equipment, United States, Average Price ($), Historic, 2003-2010 86

Table 42: Neurological Diagnostic Equipment, United States, Average Price ($), Forecast, 2010-2017 86

Table 43: Neurological Diagnostic Equipment, United States, Distribution Share by Revenue ($m), 2009-2010 87

Table 44: Neurological Diagnostic Equipment, United States, Company Share by Revenue ($m), 2009-2010 89

Table 45: Neurostimulation Devices Market, United States, Segment Contribution (%), 2010 92

Table 46: Neurostimulation Devices, United States, Revenue ($m) by Segment, Historic, 2003-2010 94

Table 47: Neurostimulation Devices, United States, Revenue ($m) by Segment, Forecast, 2010-2017 96

Table 48: Neurostimulation Devices, United States, Volume (Units) by Segment, Historic, 2003-2010 98

Table 49: Neurostimulation Devices, United States, Volume (Units) by Segment, Forecast, 2010-2017 100

Table 50: Neurostimulation Devices, United States, Average Price ($), Historic, 2003-2010 101

Table 51: Neurostimulation Devices, United States, Average Price ($), Forecast, 2010-2017 101

Table 52: Neurostimulation Devices, United States, Distribution Share by Revenue ($m), 2009-2010 102

Table 53: Neurostimulation Devices, United States, Company Share by Revenue ($m), 2009-2010 104

Table 54: Neurosurgical Products Market, United States, Segment Contribution (%), 2010 107

Table 55: Neurosurgical Products, United States, Revenue ($m) by Segment, Historic, 2003-2010 109

Table 56: Neurosurgical Products, United States, Revenue ($m) by Segment, Forecast, 2010-2017 111

Table 57: Neurosurgical Products, United States, Volume (Units) by Segment, Historic, 2003-2010 112

Table 58: Neurosurgical Products, United States, Volume (Units) by Segment, Forecast, 2010-2017 114

Table 59: Neurosurgical Products, United States, Average Price ($), Historic, 2003-2010 115

Table 60: Neurosurgical Products, United States, Average Price ($), Forecast, 2010-2017 115

Table 61: Neurosurgical Products, United States, Distribution Share by Revenue ($m), 2009-2010 116

Table 62: Neurosurgical Products, United States, Company Share by Revenue ($m), 2009-2010 118

Table 63: Radiosurgery Market, United States, Segment Contribution (%), 2010 121

Table 64: Radiosurgery, United States, Revenue ($m) by Segment, Historic, 2003-2010 123

Table 65: Radiosurgery, United States, Revenue ($m) by Segment, Forecast, 2010-2017 125

Table 66: Radiosurgery, United States, Volume (Units) by Segment, Historic, 2003-2010 127

Table 67: Radiosurgery, United States, Volume (Units) by Segment, Forecast, 2010-2017 128

Table 68: Radiosurgery, United States, Average Price ($), Historic, 2003-2010 129

Table 69: Radiosurgery, United States, Average Price ($), Forecast, 2010-2017 129

Table 70: Radiosurgery, United States, Distribution Share by Revenue ($m), 2009-2010 130

Table 71: Radiosurgery, United States, Company Share by Revenue ($m), 2009-2010 131

Table 72: Neurology Devices Market Pipeline Products 143

Table 73: Impulse Monitoring Acquires Great Lakes Intraoperative Neuromonitoring 150

Table 74: Boston Scientific Acquires Remaining Stake In Intelect Medical 151

Table 75: Vycor Medical Completes Acquisition Of NovaVision 153

Table 76: Synthes Acquires The Anspach Effort 154

Table 77: Stryker Acquires Porex Surgical 155

Table 78: Cardinal Health Sells 13.7% Stake In Carefusion 156

Table 79: HealthMed Services Acquires Neural Communicator 157

Table 80: Masimo Completes Acquisition Of SEDLine 158

Table 81: Johnson & Johnson Completes Acquisition Of Micrus Endovascular 159

Table 82: K-Kitz Acquires Bacterin In Reverse Acquisition 161

Table 83: Medtronic Acquires Axon Systems 162

Table 84: Covidien Completes Acquisition Of ev3 For $2.6 Billion 163

Table 85: Boston Scientific Enters Into Partnership With Greatbatch Medical 165

Table 86: Synergetics USA Enters Into Co-Development Agreement With Retinal Solutions 166

Table 87: EndoStim Enters Into An Agreement With Arizona State University 167

Table 88: USD to Local Currency, United States, Average Actual Rate 2003-2010 211

1.2 List of Figures

Figure 1: Neurology Devices, Market Segmentation 16

Figure 2: Neurology Devices, United States, Overall Revenue ($m), 2003-2017 17

Figure 3: Neurology Devices Market, United States, Revenue Mix ($m), 2010 19

Figure 4: Neurology Devices Market, United States, Category Contribution (%), 2010 20

Figure 5: Neurology Devices, United States, Cross-Category Analysis, 2003-2017 21

Figure 6: Neurology Devices, United States, Overall Revenue ($m), Historic, 2003-2010 22

Figure 7: Neurology Devices, United States, Overall Revenue ($m), Forecast, 2010-2017 24

Figure 8: Neurology Devices, United States, Category Volume (Units), 2003-2017 26

Figure 9: Neurology Devices, United States, Category Volume (Units), Historic, 2003-2010 27

Figure 10: Neurology Devices, United States, Category Volume (Units), Forecast, 2010-2017 29

Figure 11: Neurology Devices, United States, Company Share (%), 2010 31

Figure 12: CSF Management, Market Segmentation 33

Figure 13: CSF Management Market, United States, Revenue Mix ($m), 2010 34

Figure 14: CSF Management Market, United States, Segment Contribution (%), 2010 35

Figure 15: CSF Management, United States, Revenue ($m) by Segment, Historic, 2003-2010 36

Figure 16: CSF Management, United States, Revenue ($m) by Segment, Forecast, 2010-2017 38

Figure 17: CSF Management, United States, Volume (Units) by Segment, Historic, 2003-2010 40

Figure 18: CSF Management, United States, Volume (Units) by Segment, Forecast, 2010-2017 42

Figure 19: CSF Management, United States, Company Share (%), 2010 45

Figure 20: Interventional Neurology, Market Segmentation 46

Figure 21: Interventional Neurology Market, United States, Revenue Mix ($m), 2010 47

Figure 22: Interventional Neurology Market, United States, Segment Contribution (%), 2010 48

Figure 23: Interventional Neurology, United States, Revenue ($m) by Segment, Historic, 2003-2010 49

Figure 24: Interventional Neurology, United States, Revenue ($m) by Segment, Forecast, 2010-2017 51

Figure 25: Embolic Systems, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 53

Figure 26: Embolic Systems, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 55

Figure 27: Navigational Systems, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 57

Figure 28: Navigational Systems, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 59

Figure 29: Interventional Neurology, United States, Volume (Units) by Segment, Historic, 2003-2010 61

Figure 30: Interventional Neurology, United States, Volume (Units) by Segment, Forecast, 2010-2017 63

Figure 31: Embolic Systems, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 65

Figure 32: Embolic Systems, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 66

Figure 33: Navigational Systems, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 67

Figure 34: Navigational Systems, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 69

Figure 35: Interventional Neurology, United States, Company Share (%), 2010 73

Figure 36: Neurological Diagnostic Equipment, Market Segmentation 75

Figure 37: Neurological Diagnostic Equipment Market, United States, Revenue Mix ($m), 2010 76

Figure 38: Neurological Diagnostic Equipment Market, United States, Segment Contribution (%), 2010 77

Figure 39: Neurological Diagnostic Equipment, United States, Revenue ($m) by Segment, Historic, 2003-2010 78

Figure 40: Neurological Diagnostic Equipment, United States, Revenue ($m) by Segment, Forecast, 2010-2017 80

Figure 41: Neurological Diagnostic Equipment, United States, Volume (Units) by Segment, Historic, 2003-2010 82

Figure 42: Neurological Diagnostic Equipment, United States, Volume (Units) by Segment, Forecast, 2010-2017 84

Figure 43: Neurological Diagnostic Equipment, United States, Company Share (%), 2010 88

Figure 44: Neurostimulation Devices, Market Segmentation 90

Figure 45: Neurostimulation Devices Market, United States, Revenue Mix ($m), 2010 91

Figure 46: Neurostimulation Devices Market, United States, Segment Contribution (%), 2010 92

Figure 47: Neurostimulation Devices, United States, Revenue ($m) by Segment, Historic, 2003-2010 93

Figure 48: Neurostimulation Devices, United States, Revenue ($m) by Segment, Forecast, 2010-2017 95

Figure 49: Neurostimulation Devices, United States, Volume (Units) by Segment, Historic, 2003-2010 97

Figure 50: Neurostimulation Devices, United States, Volume (Units) by Segment, Forecast, 2010-2017 99

Figure 51: Neurostimulation Devices, United States, Company Share (%), 2010 103

Figure 52: Neurosurgical Products, Market Segmentation 105

Figure 53: Neurosurgical Products Market, United States, Revenue Mix ($m), 2010 106

Figure 54: Neurosurgical Products Market, United States, Segment Contribution (%), 2010 107

Figure 55: Neurosurgical Products, United States, Revenue ($m) by Segment, Historic, 2003-2010 108

Figure 56: Neurosurgical Products, United States, Revenue ($m) by Segment, Forecast, 2010-2017 110

Figure 57: Neurosurgical Products, United States, Volume (Units) by Segment, Historic, 2003-2010 112

Figure 58: Neurosurgical Products, United States, Volume (Units) by Segment, Forecast, 2010-2017 114

Figure 59: Neurosurgical Products, United States, Company Share (%), 2010 117

Figure 60: Radiosurgery, Market Segmentation 119

Figure 61: Radiosurgery Market, United States, Revenue Mix ($m), 2010 120

Figure 62: Radiosurgery Market, United States, Segment Contribution (%), 2010 121

Figure 63: Radiosurgery, United States, Revenue ($m) by Segment, Historic, 2003-2010 122

Figure 64: Radiosurgery, United States, Revenue ($m) by Segment, Forecast, 2010-2017 124

Figure 65: Radiosurgery, United States, Volume (Units) by Segment, Historic, 2003-2010 126

Figure 66: Radiosurgery, United States, Volume (Units) by Segment, Forecast, 2010-2017 128

Figure 67: Radiosurgery, United States, Company Share (%), 2010 131

Figure 68: Medtronic, Inc., Company Share (%),United States Neurology Devices Market, 2010 132

Figure 69: Boston Scientific Corporation, Company Share (%),United States Neurology Devices Market, 2010 133

Figure 70: St. Jude Medical, Inc., Company Share (%),United States Neurology Devices Market, 2010 134

Figure 71: Cyberonics, Inc., Company Share (%),United States Neurology Devices Market, 2010 135

Figure 72: DePuy, Inc., Company Share (%),United States Neurology Devices Market, 2010 136

Figure 73: Integra LifeSciences Holdings Corporation, Company Share (%),United States Neurology Devices Market, 2010 137Medtronic, Inc.

Boston Scientific Corporation

St. Jude Medical, Inc.

Cyberonics, Inc.

DePuy, Inc.

Integra LifeSciences Holdings Corporation

Terumo Corporation

Nihon Kohden Corporation

Elekta AB

Micrus Endovascular Corporation

Cadwell Laboratories, Inc.

ev3 Inc.

B. Braun Melsungen AG

Mizuho Ikakogyo Co., Ltd.

Accuray Incorporated

CareFusion Corporation

Natus Medical Incorporated

Covidien plc

Sophysa S.A.

KARL STORZ GmbH & Co. KG

To order this report:

: Neurology Devices Market Outlook in United States to 2017 – Neurostimulation Devices, Interventional Neurology and Others

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Contact:
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker